Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)

Omer M Ali, MD, Sahil S Nalawade, MS, Yin Xi, PhD, Ben Wagner, BM, Alexander Mazal, MD, Shane Ahlers, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Kiran A Kumar, MD MBA, Neil B Desai, MD MHS, Joseph A Maldjian, MD, Marco C Pinho, MD, Praveen Ramakrishnan Geethakumari, MD MS

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141941

Published: 2020

Journal Articles

CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A 'Real-World' Analysis of Patterns of Failure and Role of Bridging Therapy

Revathi Ravella, BA, Elizabeth Ren Zhang-Velten, MD PhD, Farrukh T Awan, MD, Syed M Rizvi, MD, Jennifer L Shah, MD, Neil B Desai, MD MHS, Praveen Ramakrishnan Geethakumari, MD MS, Kiran A Kumar, MD MBA

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141445

Published: 2020

Journal Articles

Comparison of Demographics, Treatment Patterns and Outcomes Among Primary Central Nervous System Lymphoma (PCNSL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution within the Same Healthcare System

Akshat M Patel, Omer M Ali, MD, Radhika Kainthla, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Neil B Desai, MD MHS, Robert Timmerman, MD, Kiran A Kumar, MD MBA, Praveen Ramakrishnan Geethakumari, MD MS

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-138568

Published: 2020